SC 13G/A

OVASCIENCE, INC. SCHEDULE 13G, AMENDMENT 1

Company: Tempest Therapeutics, Inc.
Filed: February 6, 2014
Accession Number: 0000897423-14-000003

View Document ↗ View on SEC.gov ↗